J.Safra Asset Management Corp Sorrento Therapeutics, Inc. Transaction History

J.Safra Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.24 - $2.33 $16 - $30	-13 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.0 - $4.9 $28 - $68	-14 Reduced 51.85%	13 $5,000
Q4 2021 Feb 04, 2022	SELL	$4.65 - $7.23 $6,277 - $9,760	-1,350 Reduced 98.04%	27 $6,000
Q4 2021 Jan 31, 2022	SELL	$4.65 - $7.23 $21,403 - $33,279	-4,603 Reduced 76.97%	1,377 $6,000
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $10,345 - $40,424	5,980 New	5,980 $37,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on J.Safra Asset Management Corp with notifications on news.